Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Drug screening—beyond the bottleneck


High-throughput screening still has a long way to go if it is to achieve its often-touted potential.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: Big is beautiful.


  1. Kell, D. Screensavers: trends in high-throughput analysis. Trends Biotechnol. 17, 89–91 (1999).

    Article  CAS  Google Scholar 

  2. Archer, R. Towards the drug discovery factory. J. Assoc. Lab. Automat. 3, 4 (1998).

    Google Scholar 

  3. Frederickson, R. Macromolecular matchmaking: advances in two-hybrid and related technologies. Curr. Opin Biotechnol. 9, 90– 96 (1998).

    Article  CAS  Google Scholar 

  4. Young, K. et al. Identification of a calcium channel modulator using a high-throughput yeast two-hybrid screen. Nat. Biotechnol. 16, 946–950 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dove, A. Drug screening—beyond the bottleneck. Nat Biotechnol 17, 859–863 (1999).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing